Naz Rahman

Stock Analyst at Maxim Group

(0)
# 5009
Out of 5,240 analysts
46
Total ratings
20.00%
Success rate
-38.32%
Average return
21 Stocks
Name Action Price Target Current % Upside Ratings Updated
NeuroSense Therapeut...
Downgrades: Hold
n/a
n/a n/a 2 Dec 16, 2024
Cingulate
Upgrades: Buy
n/a
n/a n/a 4 Nov 20, 2024
Palisade Bio
Maintains: Buy
23 8
1.73 362.43% 7 Nov 13, 2024
Silexion Therapeutic...
Initiates Coverage On: Buy
9
1.77 408.47% 1 Nov 1, 2024
PainReform
Downgrades: Hold
n/a
n/a n/a 2 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 4 Oct 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
3
0.8 275% 1 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
120 120
33.87 254.3% 4 Jun 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Mar 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 4
0.58 589.66% 2 Mar 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Jan 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
4
0.31 1190.32% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Nov 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
5
1.64 204.88% 1 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 20
3.49 473.07% 2 May 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Aug 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 May 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
3.53 69.97% 1 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Dec 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
27
n/a n/a 1 Mar 31, 2021